Skip to contentClarengateINTELLIGENCE
Companies/SC362273

Mgb Biopharma Limited

Private Limited Company · Edinburgh

Compulsory Liquidation / Winding-upUnited KingdomIncorporated 2009Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2023-08-31

IXBRL · 115 source facts · 26 selected values

Not assessed
legacy record
Reporting period
2022-09-01 to 2023-08-31
Extraction status
Legacy / not assessed
Numeric facts
69
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2023-01-01.xsd
Currency
GBP
Source identifier
Prod224_1966_SC362273_20230831
Source archive
Accounts_Monthly_Data-April2024.zip

Accounts to 2022-08-31

IXBRL · 122 source facts · 26 selected values

Not assessed
legacy record
Reporting period
2021-09-01 to 2022-08-31
Extraction status
Legacy / not assessed
Numeric facts
73
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_0015_SC362273_20220831
Source archive
Accounts_Monthly_Data-May2023.zip

Accounts to 2021-08-31

IXBRL · 186 source facts · 36 selected values

Not assessed
legacy record
Reporting period
2020-09-01 to 2021-08-31
Extraction status
Legacy / not assessed
Numeric facts
134
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0106_SC362273_20210831
Source archive
Accounts_Monthly_Data-May2022.zip

Registered details

SC362273
Status
Liquidation
Type
Private Limited Company
Incorporated
2009-07-07
Jurisdiction
—
Registered office
86A, GEORGE STREET, EDINBURGH, EH2 3BU

Classification

1 SIC codes
23108

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

1 SH01-derived rounds
2024-08-26
£255,000 raised
£967,856 estimated post-money
Venture

Research and innovation

4 matched grants
Phase IIa Clinical Trial for a Novel Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)Lead
Innovate UK · Collaborative R&D · 2018-02-01 – 2020-03-31
£2,780,569
awarded
A Dynamic Perspective on DNA-binding
STFC · Research Grant · 2014-12-01 – 2015-11-30 · with 1 other participant
£48,437
whole project
Phase I study to assess tolerability, safety and PK of MGB-BP-3 in healthy volunteersLead
Innovate UK · Collaborative R&D · 2014-08-01 – 2016-01-31
£1,319,669
awarded
Parenteral Formulation for New Class (DNA Minor Groove Binder) Anti-InfectiveLead
Innovate UK · GRD Proof of Concept · 2012-04-01 – 2013-03-31
£100,000
awarded